Insider Transactions

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Insider Transactions

Date Name Title Type Shares Traded Price Range
Dec 19, 2014
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 03, 2013
EVP & Chief Operating Officer
EVP & Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jun 03, 2013
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Sep 07, 2012
EVP & Chief Operating Officer
EVP & Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Oct 04, 2011
Director, Chairman, CEO & President
Director, Chairman, CEO & President Bona fide gift 100,000 --
Oct 04, 2011
Director, Chairman, CEO & President
Director, Chairman, CEO & President Bona fide gift 100,000 --
Jun 12, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Oct 11, 2010
Acting Chief Financial Officer
Acting Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jul 01, 2010
Sr. Vice President Finance
Sr. Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 $3.92
Jun 26, 2009
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 $6.09
Apr 23, 2009
Vice President Finance
Vice President Finance Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 100,000 $1.15
Dec 06, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 $3.15
Jul 20, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 08, 2006
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Sep 26, 2006
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 06, 2005
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jan 03, 2005
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jul 10, 2004
President Oncology Division
President Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,750 $4.23
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,750 --
Oct 04, 2011
Director, Chairman, CEO & President
Director, Chairman, CEO & President Bona fide gift 90,750 --
Oct 04, 2011
Director, Chairman, CEO & President
Director, Chairman, CEO & President Bona fide gift 90,750 --
Feb 18, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Feb 18, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Sep 05, 2003 Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.